2023 - Research.com Chemistry in United Kingdom Leader Award
2022 - Research.com Chemistry in United Kingdom Leader Award
2013 - Member of the National Academy of Sciences
2005 - Davy Medal, Royal Society of London (UK) For his work on the application of NMR and other structural methods for studying protein folding and misfolding, especially the formation of amyloid fibrils, leading to novel insights on protein structure and folding
1999 - Interdisciplinary Prize, Royal Society of Chemistry (UK)
1981 - Corday–Morgan Prize, Royal Society of Chemistry (UK)
Christopher M. Dobson focuses on Protein folding, Biochemistry, Crystallography, Protein structure and Fibril. His Protein folding research incorporates elements of Biophysics, Circular dichroism, Folding, Computational biology and Kinetics. His Biochemistry research incorporates themes from Amyloid disease and Amyloid fibril.
His research integrates issues of Nuclear magnetic resonance spectroscopy, Protein secondary structure and Hydrogen bond in his study of Crystallography. As a part of the same scientific family, Christopher M. Dobson mostly works in the field of Protein structure, focusing on Acylphosphatase and, on occasion, Mutation. His Fibril study which covers Amyloid that intersects with Sequence, Amyloidosis, Monomer and Molecule.
Christopher M. Dobson mostly deals with Biophysics, Protein folding, Crystallography, Biochemistry and Amyloid. His Biophysics research focuses on Protein aggregation and how it relates to In vitro. His Protein folding research integrates issues from Protein structure, Computational biology and Folding.
His study explores the link between Crystallography and topics such as Nuclear magnetic resonance spectroscopy that cross with problems in Analytical chemistry. The various areas that he examines in his Biochemistry study include Amyloid disease and Alpha-synuclein. His Amyloid study frequently draws connections between related disciplines such as Nucleation.
His primary areas of study are Biophysics, Protein aggregation, Amyloid, Protein folding and Cell biology. A large part of his Biophysics studies is devoted to Fibril. Christopher M. Dobson usually deals with Fibril and limits it to topics linked to Kinetics and Nucleation.
Protein aggregation is a primary field of his research addressed under Biochemistry. His studies in Amyloid integrate themes in fields like Microfluidics and Fluorescence. Protein folding connects with themes related to Protein structure in his study.
His primary areas of investigation include Biophysics, Protein aggregation, Alpha-synuclein, Biochemistry and Protein folding. His research in Biophysics is mostly concerned with Fibril. His studies deal with areas such as Proteome, Proteostasis, Chaperone and Drug discovery as well as Protein aggregation.
His research investigates the link between Biochemistry and topics such as Neurodegeneration that cross with problems in Caenorhabditis elegans. His work deals with themes such as Amyloid fibril, Neuroscience, Protein structure, Computational biology and Peptide, which intersect with Protein folding. His Protein structure research includes elements of Folding, Biomolecule, Nuclear magnetic resonance spectroscopy and Ribosome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Protein Misfolding, Functional Amyloid, and Human Disease
Fabrizio Chiti;Christopher M. Dobson.
Annual Review of Biochemistry (2006)
Protein folding and misfolding
Christopher M. Dobson.
Nature (2003)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.
Monica Bucciantini;Elisa Giannoni;Fabrizio Chiti;Fabrizio Chiti;Fabiana Baroni.
Nature (2002)
Protein misfolding, evolution and disease
Christopher M. Dobson.
Trends in Biochemical Sciences (1999)
The amyloid state and its association with protein misfolding diseases
Tuomas P. J. Knowles;Michele Vendruscolo;Christopher M. Dobson.
Nature Reviews Molecular Cell Biology (2014)
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution
Massimo Stefani;Christopher M. Dobson.
Journal of Molecular Medicine (2003)
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Fabrizio Chiti;Christopher M. Dobson.
Annual Review of Biochemistry (2017)
Designing conditions for in vitro formation of amyloid protofilaments and fibrils
Fabrizio Chiti;Paul Webster;Niccolò Taddei;Anne Clark.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
David R. Booth;Margaret Sunde;Vittorio Bellotti;Vittorio Bellotti;Carol V. Robinson.
Nature (1997)
Rationalization of the effects of mutations on peptide and protein aggregation rates.
Fabrizio Chiti;Massimo Stefani;Niccolò Taddei;Giampietro Ramponi.
Nature (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Cambridge
University of Cambridge
University of Florence
University of Oxford
University of Oxford
Lund University
University of Cambridge
University of Leeds
ETH Zurich
University of Cambridge
Chiba University
University of Petroleum and Energy Studies
Stony Brook University
Institut Pasteur
Chicago Zoological Society
Commonwealth Scientific and Industrial Research Organisation
Kyoto University
King's College London
Stony Brook University
University of Bath
University of California, San Diego
University of Washington
Curtin University
University of Wisconsin–Milwaukee
Johns Hopkins University
Harvard University